William Graham Richards
Oprichter bij Oxford Drug Design Ltd.
Profiel
William Graham Richards is the founder of Oxford Drug Design Ltd.
(founded in 2001) and serves as the Chairman.
He is also the founder of Oxford Molecular Group Plc.
Mr. Richards's current job is as an Advisor at o2h Ltd.
His former jobs include being the Chairman of the Chemistry Department at the University of Oxford in 2006, Chairman of OMass Therapeutics Ltd., Non-Executive Director of Oxeco Plc, Non-Executive Director of IP Group Plc from 2012 to 2013, Director of Oxford University Innovation Ltd., Non-Executive Director of Tissue Regenix Group Plc from 2006 to 2010, Director of TdeltaS Ltd., and Non-Executive Director of Crysalin Ltd.
Actieve functies van William Graham Richards
Bedrijven | Functie | Begin |
---|---|---|
Oxford Drug Design Ltd.
Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Oxford Drug Design Ltd. develops application of new technologies to drive computer-aided drug discovery. It specializes in drug discovery, molecular modeling, lead identification and optimisation, formulation modeling and preclinical studies. The company was founded by W. Graham Richards in 2001 and is headquartered in Oxford, the United Kingdom. | Oprichter | 01-01-2001 |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Consultant / Adviseur | - |
Eerdere bekende functies van William Graham Richards
Bedrijven | Functie | Einde |
---|---|---|
IP GROUP PLC | Voorzitter | 10-09-2009 |
Oxeco Plc
Oxeco Plc Financial ConglomeratesFinance Oxeco Plc is a investment company. It invests and acquires assets or companies in the technology and science sectors as well as to develop businesses in this field. The company was founded on October 17, 2006 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | 30-06-2010 |
TISSUE REGENIX GROUP PLC | Directeur/Bestuurslid | 29-06-2010 |
University of Oxford | Corporate Officer/Principal | 30-06-2006 |
OMass Therapeutics Ltd.
OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services OMass Therapeutics Ltd. develops native mass spectrometry platform The company was founded by Dame Carol Robinson and is headquartered in Oxford, the United Kingdom. | Voorzitter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
IP GROUP PLC | Commercial Services |
TISSUE REGENIX GROUP PLC | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Oxeco Plc
Oxeco Plc Financial ConglomeratesFinance Oxeco Plc is a investment company. It invests and acquires assets or companies in the technology and science sectors as well as to develop businesses in this field. The company was founded on October 17, 2006 and is headquartered in London, the United Kingdom. | Finance |
Oxford Molecular Group Plc | Health Technology |
Oxford Drug Design Ltd.
Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Oxford Drug Design Ltd. develops application of new technologies to drive computer-aided drug discovery. It specializes in drug discovery, molecular modeling, lead identification and optimisation, formulation modeling and preclinical studies. The company was founded by W. Graham Richards in 2001 and is headquartered in Oxford, the United Kingdom. | Technology Services |
Oxford University Innovation Ltd.
Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Finance |
TdeltaS Ltd.
TdeltaS Ltd. Miscellaneous Commercial ServicesCommercial Services TdeltaS Ltd. is a British company that provides commercial, physical, and biological research and development services. The company is based in Thame, UK and was founded in 2005. | Commercial Services |
Crysalin Ltd.
Crysalin Ltd. BiotechnologyHealth Technology Crysalin Ltd. develops crysalin lattice technology for protein structure determination. Its portfolio includes crysalins, a protein-based nanotechnology for application in protein structure determination, as well as biosensor development and optoelectronics. The company was founded by Martin Noble and John Sinclair in June 2007 and is headquartered in Oxfordshire, the United Kingdom. | Health Technology |
OMass Therapeutics Ltd.
OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services OMass Therapeutics Ltd. develops native mass spectrometry platform The company was founded by Dame Carol Robinson and is headquartered in Oxford, the United Kingdom. | Commercial Services |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Finance |